NerdWallet, Inc. is an independent publisher and comparison service, not an investment advisor. Its articles, interactive tools and other content are provided to you for free, as self-help tools and for informational purposes only. They are not intended to provide investment advice. NerdWallet does not and cannot guarantee the accuracy or applicability of any information in regard to your individual circumstances. Examples are hypothetical, and we encourage you to seek personalized advice from qualified professionals regarding specific investment issues. Our estimates are based on past market performance, and past performance is not a guarantee of future performance.
We believe everyone should be able to make financial decisions with confidence. And while our site doesn’t feature every company or financial product available on the market, we’re proud that the guidance we offer, the information we provide and the tools we create are objective, independent, straightforward — and free.
So how do we make money? Our partners compensate us. This may influence which products we review and write about (and where those products appear on the site), but it in no way affects our recommendations or advice, which are grounded in thousands of hours of research. Our partners cannot pay us to guarantee favorable reviews of their products or services. Here is a list of our partners.
Best-Performing Marijuana and Cannabis ETFs (July 2026)
Marijuana exchange-traded funds give you the chance to invest in a range of cannabis-related companies. But don’t expect stability from these budding funds.
Chris Davis is a Managing Editor on the Investing team. He has passed the Series 65 (Uniform Investment Adviser Law Exam) and covered the stock market, investing strategies, investment accounts and cryptocurrency. His work has appeared in The Associated Press, The Washington Post, MSN, Yahoo Finance, MarketWatch, Newsday and TheStreet.
Arielle O’Shea leads the investing, advisory and taxes content teams at NerdWallet. She has covered personal finance and investing for 20 years, and was a senior writer and spokesperson at NerdWallet before becoming an editor. Previously, she was a researcher and reporter for leading personal finance journalist and author Jean Chatzky, a role that included developing financial education programs, interviewing subject matter experts and helping to produce television and radio segments. Arielle has appeared on the "Today" show, NBC News and ABC's "World News Tonight," and has been quoted in national publications including The New York Times, MarketWatch and Bloomberg News. She is based in Charlottesville, Virginia.
Published in
Updated
How is this page expert verified?
NerdWallet's content is fact-checked for accuracy, timeliness and relevance. It undergoes a thorough review process involving writers and editors to ensure the information is as clear and complete as possible.
Individual marijuana stocks tend to get most of the attention, but marijuana ETFs — which let you invest in multiple companies across the industry’s verticals, from product development to consumption — may be a better fit for some investors.
For example, by purchasing a share of the AdvisorShares Pure US Cannabis ETF (MSOS), the largest cannabis ETF by assets under management, you gain exposure to companies across the marijuana industry, including Curaleaf, Trulieve Cannabis Corp., Green Thumb Industries, Verano, Glass House Brands and Cresco Labs.
Marijuana ETFs also help spread risk across multiple companies and segments, rather than concentrating it in a single stock. This approach, known as diversification, is a core investing principle and is especially important in a relatively new and volatile sector like cannabis, where headlines can send stocks soaring — or cause their collapse. Most recently, the Justice Department announced a new rule that moves FDA-approved medical marijuana and that which is sold in a state where it's legal from a Schedule I drug to a Schedule III drug
Below are the cannabis ETFs available to U.S. investors (excluding the over-the-counter market) with positive returns as of July 2026.
The best-performing cannabis ETF by one-year return is Roundhill Cannabis ETF (WEED), which is up 116.50%.
Ticker
Company
Performance (Year)
WEED
Roundhill Cannabis ETF
116.50%
MSOS
AdvisorShares Pure US Cannabis ETF
108.54%
CNBS
Amplify Seymour Cannabis ETF
87.27%
YOLO
AdvisorShares Pure Cannabis ETF
48.50%
MJ
Amplify Alternative Harvest ETF
40.25%
Source: Finviz. Data is current as of July 1, 2026, and is intended for informational purposes only.
Marijuana ETFs vs. stocks
There are hundreds of cannabis stocks to choose from, many of them risky penny stocks or stocks of companies with extremely small market capitalizations. Given the industry’s young age, there’s ample room for shakeouts that could significantly affect a stock’s price. There will likely be many losers, and it’s hard to predict how many potential winners there will be. The current state of the industry makes an already risky strategy — picking individual stocks — even riskier.
Marijuana ETFs still come with considerable risk, but you’ll at least broaden your exposure to dozens of companies. If one company in the fund fails, ideally those losses will be offset by another company’s success. It’s true that you could miss out on the sky-high returns of an individual breakout stock, but investing in ETFs could help you avoid the significant losses investors are likely to see in such an unproven industry.
NerdWallet's ratings are determined by our editorial team. The scoring formula for online brokers and robo-advisors takes into account over 15 factors, including account fees and minimums, investment choices, customer support and mobile app capabilities.
NerdWallet's ratings are determined by our editorial team. The scoring formula for online brokers and robo-advisors takes into account over 15 factors, including account fees and minimums, investment choices, customer support and mobile app capabilities.
NerdWallet's ratings are determined by our editorial team. The scoring formula for online brokers and robo-advisors takes into account over 15 factors, including account fees and minimums, investment choices, customer support and mobile app capabilities.
NerdWallet's ratings are determined by our editorial team. The scoring formula for online brokers and robo-advisors takes into account over 15 factors, including account fees and minimums, investment choices, customer support and mobile app capabilities.
Investing in cannabis — including cannabis ETFs — still comes with considerable risk. While regulatory risk appears to be a lesser concern these days, the sheer unpredictability in business models and operations of such a young industry could significantly and quickly alter the future landscape and, in turn, the value of marijuana stocks and ETFs.
Regulation
While recreational marijuana consumption and possession are now legal in several states (and medical marijuana is legal in even more), in the eyes of the federal government, it’s still an illegal substance. The recent shift from Schedule I to Schedule III will open up more avenues for medical research and commercialization, but it stops short of full, federal recreational legalization.
Financing and banking
While the earliest dispensaries and marijuana businesses may have struggled to secure traditional financing and banking services, that isn’t as much of a concern today, and further change could be on the horizon.
The Secure and Fair Enforcement Regulation Banking Act was reintroduced in the House in 2023 but has still not been passed into law. If it becomes law (and the latest news from the Justice Department could signal more urgency to move on the proposed legislation), it would help protect depository institutions that supply financial services to marijuana companies.
The number of depository institutions providing banking services to marijuana companies has certainly increased over the years. Still, many of these developments aren't yet concrete, and the full landscape is still being formed.
Volatility
If you’re a new investor or are looking for predictability, there are other index funds and ETFs better suited for you. But if you’re willing to stomach the volatility of an uncertain market in exchange for getting in at an extremely early stage — and your portfolio is in a well-diversified, healthy state — you may have a case for investing in cannabis ETFs.
NerdWallet writers are subject matter authorities who use primary, trustworthy sources to inform their work, including peer-reviewed studies, government websites, academic research and interviews with industry experts. All content is fact-checked for accuracy, timeliness and relevance. You can learn more about NerdWallet's high standards for journalism by reading our editorial guidelines.